Here’s another attempt at a continuous glucose monitoring device.
Glucon announced last week the recent trial results of its flagship product, Aprise, a continuous, non-invasive, glucose monitoring device. The data was presented by Glucon V.P. of R&D Dr. Benny Pesach at the Diabetes Technology Society Standards Workshop on November 10, 2005 at the Fifth Annual Diabetes Technology Meeting in San Francisco.